Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Université Paris Sciences Et Lettres is managing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This prosecution involves a distinct examiner and a distinct art unit, indicating a singular point of contact for the company's current pending matters. The busiest examiner for this portfolio is RONEY, CELESTE A, who is handling the 1 busiest examiner pending action. This focused arrangement suggests that the university's current pharmaceutical interests are being scrutinized by a single specialized official.
With only a pending office action, the outcome of the current prosecution depends solely on the interaction with RONEY, CELESTE A. The presence of a distinct art unit suggests that the technical review is specialized within a specific pharmaceutical or biological field. This focused data set implies that the applicant can dedicate resources to addressing the specific concerns of the examiner without the distraction of a broader portfolio. Practitioners should prioritize understanding the specific examination style of the official to navigate the technical requirements of the unit. The lack of other pending actions means that this matter represents the entirety of the company's current administrative focus in this technology area.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RONEY, CELESTE A | 1 | 63.0% | +17.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18881505 | EXTRACELLULAR VESICLES FUNCTIONALIZED WITH AN ERV SYNCITIN AND USES THEREOF FOR CARGO DELIVERY | RONEY, CELESTE A | — |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18881505 | EXTRACELLULAR VESICLES FUNCTIONALIZED WITH AN ERV SYNCITIN AND USES THEREOF FOR CARGO DELIVERY | RONEY, CELESTE A | 1612 | §103DP | Non-Final OA | — | Pending | Jan 06, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversité Paris Sciences Et Lettres has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Celeste A Roney has the most, with 1 of Université Paris Sciences Et Lettres's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
